CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia treated with idarubicin and cytosine arabinoside

Hiroshi Handa, Sachiko Motohashi, Kazuo Isozumi, Satoru Komatsumoto, Masaharu Nara

Research output: Contribution to journalArticlepeer-review

10 Citations (Scopus)

Fingerprint

Dive into the research topics of 'CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia treated with idarubicin and cytosine arabinoside'. Together they form a unique fingerprint.

Medicine & Life Sciences